Eledon Pharmaceuticals, Inc. (ELDN) Tops Q4 EPS by 4c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q4 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance